| For: | Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. World J Gastroenterol 2018; 24(17): 1888-1900 [PMID: 29740204 DOI: 10.3748/wjg.v24.i17.1888] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i17/1888.htm |
| Number | Citing Articles |
| 1 |
A.P. Lytvynenko, O.T. Blashkiv, T.Yu. Voznesenska. FUNCTIONAL GASTROINTESTINAL DISORDERS UNDER THE CONDITIONS OF EXPERIMENTAL MODELS OF STRESS. Fiziolohichnyĭ zhurnal 2025; 71(2) doi: 10.15407/fz71.02.106
|
| 2 |
Martina Rekatsina, Giustino Varrassi. Emerging potential therapies for chronic abdominal visceral pain: an overview. Advancements in Health Research 2024; 1(1) doi: 10.4081/ahr.2024.2
|
| 3 |
Walter Cabri, Paolo Cantelmi, Dario Corbisiero, Tommaso Fantoni, Lucia Ferrazzano, Giulia Martelli, Alexia Mattellone, Alessandra Tolomelli. Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.697586
|
| 4 |
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann, C. Pehl. Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019. Zeitschrift für Gastroenterologie 2022; 60(10) doi: 10.1055/a-1880-1928
|
| 5 |
Joshua R. Barton, Annie K. Londregan, Tyler D. Alexander, Ariana A. Entezari, Manuel Covarrubias, Scott A. Waldman. Enteroendocrine cell regulation of the gut-brain axis. Frontiers in Neuroscience 2023; 17 doi: 10.3389/fnins.2023.1272955
|
| 6 |
Stuart M. Brierley, Luke Grundy, Joel Castro, Andrea M. Harrington, Gerhard Hannig, Michael Camilleri. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends in Pharmacological Sciences 2022; 43(2) doi: 10.1016/j.tips.2021.11.002
|
| 7 |
Sarah Scuderi, Giovanna Casili, Marika Lanza, Alessio Ardizzone, Luca Pantaleo, Michela Campolo, Irene Paterniti, Laura Cucinotta, Salvatore Cuzzocrea, Emanuela Esposito. RETRACTED: Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model. International Journal of Molecular Sciences 2022; 23(4) doi: 10.3390/ijms23042269
|
| 8 |
Bowen Tian, Xiaogang Xu, Lin Li, Yan Tian, Yanqing Liu, Yide Mu, Jieting Lu, Kai Song, Junjian lv, Qiuming He, Wei Zhong, Huimin Xia, Chaoting Lan. Epigenetic Insights Into Necrotizing Enterocolitis: Unraveling Methylation-Regulated Biomarkers. Inflammation 2024; 48(1) doi: 10.1007/s10753-024-02054-x
|
| 9 |
Alison Accarie, Tim Vanuytsel. Animal Models for Functional Gastrointestinal Disorders. Frontiers in Psychiatry 2020; 11 doi: 10.3389/fpsyt.2020.509681
|
| 10 |
Huiling Zeng, Mingyang Ma, Xiuju Peng, Yangyang Xie, Angel Xie, Bo Deng, Jiang Ouyang, Wei Tao, Pei Yang, Wei He. Oral Delivery Strategies for Biological Drugs. Small Methods 2025; 9(7) doi: 10.1002/smtd.202401355
|
| 11 |
Lu-lu Ren, Jia-yi Zhou, Shao-jie Liang, Xiu-qi Wang. Impaired intestinal stem cell activity in ETEC infection: enterotoxins, cyclic nucleotides, and Wnt signaling. Archives of Toxicology 2022; 96(5) doi: 10.1007/s00204-021-03213-x
|
| 12 |
Chengfeng Xing, Tao Zhang, Xiaolin Liu, Canmei Li, Gang Yang, Hairong Zhang, Rui Wang, Kunhua Wang, Yinglei Miao, Danfeng Lan. Guanylin ligand protects the intestinal immune barrier by activating the guanylate cyclase-C signaling pathway. Acta Histochemica 2022; 124(1) doi: 10.1016/j.acthis.2021.151811
|
| 13 |
Thomas Kremsmayr, Aws Aljnabi, Juan B. Blanco-Canosa, Hue N. T. Tran, Nayara Braga Emidio, Markus Muttenthaler. On the Utility of Chemical Strategies to Improve Peptide Gut Stability. Journal of Medicinal Chemistry 2022; 65(8) doi: 10.1021/acs.jmedchem.2c00094
|
| 14 |
Laura López-Gómez, Ana Bagüés, José Antonio Uranga, Raquel Abalo. A Comprehensive Overview of Irritable Bowel Syndrome. 2020; doi: 10.1016/B978-0-12-821324-7.00012-5
|
| 15 |
Charles F. Barish, Robert A. Crozier, Patrick H. Griffin. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation. Current Medical Research and Opinion 2019; 35(1) doi: 10.1080/03007995.2018.1527303
|
| 16 |
Dong-ha Kim, Ji-Su Kim, Jae-Hee Kwon, In-Sook Kwun, Moon-Chang Baek, Gi-Seok Kwon, Wiramon Rungratanawanich, Byoung-Joon Song, Do-Kyun Kim, Hyo-Jung Kwon, Young-Eun Cho. Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes. Antioxidants 2023; 12(10) doi: 10.3390/antiox12101886
|
| 17 |
Woo-Gyun Choi, Byung Joo Kim. Astragaloside IV from Astragalus membranaceus Fisch. ex Bunge Mitigates DSS-Induced Colitis via Anti-Inflammatory and Antioxidant Modulation of the Gut–Liver–Brain Axis. Antioxidants 2026; 15(4) doi: 10.3390/antiox15040474
|
| 18 |
Ariana A. Entezari, Adam E. Snook, Scott A. Waldman. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential. Expert Opinion on Therapeutic Targets 2021; 25(5) doi: 10.1080/14728222.2021.1937124
|
| 19 |
Abdulkreem Al-Juhani, Mahmoud S Desoky, Marwah Nasir Ahmad, Abdulrahman Alharthi, Rawiyah A Alkabkabi, Lujain Suhaqi, Jana H Alzahrani, Taif A Alotibi, Fatimah Almadih, Rodan Desoky. Tenapanor for Irritable Bowel Syndrome With Constipation (IBS-C): A Systematic Review of Randomized Trials Assessing Food and Drug Administration (FDA) Composite Response, Durability, and Risk-of-Bias (RoB-2). Cureus 2025; doi: 10.7759/cureus.93337
|
| 20 |
Morgan Sendzischew Shane, Johannah Ruddy, Michael Cline, David Rosenbaum, Susan Edelstein, Baharak Moshiree. Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States. Clinical and Experimental Gastroenterology 2024; doi: 10.2147/CEG.S464375
|
| 21 |
Jeffrey A. Rappaport, Scott A. Waldman. The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00299
|
| 22 |
David O. Prichard, Adil E. Bharucha. Recent advances in understanding and managing chronic constipation. F1000Research 2018; 7 doi: 10.12688/f1000research.15900.1
|
| 23 |
David S. Weinberg, Nathan R. Foster, Gary Della’Zanna, Ryan P. McMurray, Walter K. Kraft, Angela Pallotto, David M. Kastenberg, Leo C. Katz, Christopher H. Henry, Stephanie M. Moleski, Paul J. Limburg, Scott A. Waldman. Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers. Cancer Biology & Therapy 2021; 22(10-12) doi: 10.1080/15384047.2021.1967036
|
| 24 |
Liangen Yu, Yihang Li. Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders. Biomedicines 2022; 10(10) doi: 10.3390/biomedicines10102577
|
| 25 |
Lin Chang, Shahnaz Sultan, Anthony Lembo, G. Nicholas Verne, Walter Smalley, Joel J. Heidelbaugh. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology 2022; 163(1) doi: 10.1053/j.gastro.2022.04.016
|
| 26 |
Joshua R. Barton, Annie K. Londregran, Tyler D. Alexander, Ariana A. Entezari, Shely Bar-Ad, Lan Cheng, Angelo C. Lepore, Adam E. Snook, Manuel Covarrubias, Scott A. Waldman. Intestinal neuropod cell GUCY2C regulates visceral pain. Journal of Clinical Investigation 2023; 133(4) doi: 10.1172/JCI165578
|
| 27 |
Rachel Colbran, Leila Neshatian. Laxative logic: when lifestyle is not enough. Current Opinion in Gastroenterology 2026; 42(1) doi: 10.1097/MOG.0000000000001137
|